| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217311 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 9 Pages |
Abstract
High baseline primary tumor MTV was associated with worse treatment outcomes in this limited patient subset of RTOG 0522. Additional confirmatory work will be required to validate primary tumor MTV as a prognostic imaging biomarker for patient stratification in future trials.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
David L. MD, Jonathan MS, Min MD, PhD, David I. MD, FACR, Adam CNMT, PET, NCT, RT (N), Anthony RT (R) (CT) (MR), CIIP, K. Kian MD, PhD, Andy M. MD, Adam S. MD, FASTRO, Christopher U. MD, FACR, Paul MD, Robert MD, FASTRO, John MD, Qiang MD, PhD,